Archive for 2009
Dec 31st, 2009
_______________________________
Taro Pharmaceutical Industries Ltd. (“Taro,” the “Company,” Pink Sheets: TAROF) announced that at its Annual General Meeting of Shareholders held today in Haifa, Israel, the Company’s shareholders voted to elect all of the directors who were up for election with the exception of the statutory external directors. The shareholders also approved the ratification of indemnification for non-executive directors and the appointment of the Company’s independent auditors.
With the growth activities we had this year, I am very excited and pleased about the future of Crown Equity Holding
Dec 31st, 2009
_______________________________
On December 21, 2009, all unconverted shares of The Alpine Group, Inc. (PINKSHEETS: APNI) series A cumulative convertible stock, par value $1.00 per share ("Alpine Series A Preferred Stock") ceased to be convertible in accordance with the terms of the Certificate of Designations therefor. At September 30, 2009, there were 12,159 shares of Alpine Series A Preferred Stock outstanding with an aggregate liquidation value of $4.6 million. As at December 21, 2009, 7,806 shares of Alpine Series A Preferred stock with an aggregate stated liquidation value of $3.0 million were converted into 5,799,
Dec 31st, 2009
_______________________________
QED Connect, Inc. ("QED Connect") (PINKSHEETS: QEDN), an innovative, software-as-a-service (SaaS) provider for the information security market, today announced that the merger with Southeastern Retail Services, Inc., d/b/a "ProRemote Solutions" ("ProRemote Solutions") is proceeding as planned with an expected close date of mid January 2010 subject to final approval by the respective Boards of Directors.
ATWEC Technologies (PINKSHEETS: ATWT) CEO Alex Wiley expressed today he is very optimistic about the company's future. The state of the economy is tough but ATWEC is committed to providing
Dec 31st, 2009
_______________________________
Emergent Health Corp. (PINKSHEETS: EMGE) (PINKSHEETS: EMEG) Emergent (the "Company") is pleased to announce its forward stock split of 11 shares for each 10 shares owned is effective for shareholders of record today 12/31/09. All fractional shares will be rounded off to the next whole number.
Simulated Environment Concepts, Inc. (PINKSHEETS: SMEV), makers of the high pressurized dry water massage and relaxation station SpaCapsule, announced that it has completed negotiations with the French company Zen & O, securing a multi-million dollar deal to manufacture 250 SpaCapsules over the n
Dec 31st, 2009
_______________________________
Implant Sciences Corporation (OTCBB:IMSC), a high technology supplier of systems and sensors for homeland security markets, today announced new initiatives to target the U.S. market in aviation security for its products and technologies, based on recent events and the company’s international successes in transportation and aviation security.
Rentech, Inc. (NYSE AMEX: RTK) today confirmed that purported class-action lawsuits were filed and announced on December 29, 2009 and December 30, 2009 against the Company and certain of its officers and/or directors alleging that during the periods
Dec 31st, 2009
_______________________________
Levi & Korsinsky is investigating the Board of Directors of Quixote Corp. (“Quixote” or the “Company”) (NasdaqGM: QUIX) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to sell the Company to Trinity Industries, Inc. (Trinity") (NYSE: TRN). Under the terms of the deal, Quixote shareholders are to receive $6.38 in cash for each share of Quixote common stock they own for a total transaction value of approximately $61 million.
Wells Fargo & Company’s (NYSE: WFC) board of directors approved a grant of retention perfor
Dec 31st, 2009
_______________________________
Marvel Entertainment, Inc. (NYSE: MVL), a global character-based entertainment and licensing company founded in 1939, announced that at a special meeting held this morning, Marvel stockholders approved the adoption of the Agreement and Plan of Merger entered into by Marvel and The Walt Disney Company (“Disney”), which provides for a merger in which Marvel will become a wholly-owned subsidiary of Disney. Marvel anticipates that the merger, which, based on the closing price of Disney’s common stock on December 30, 2009, has an estimated value of approximately $4.3 billion, will be comp
Dec 31st, 2009
_______________________________
Assured Guaranty Ltd. (NYSE: AGO) (“Assured Guaranty” or the “Company”) today announced that the re-listing of the following debt securities (the “Securities”) on the New York Stock Exchange (the “NYSE”) of Assured Guaranty’s subsidiary, Financial Security Assurance Holdings Ltd. (“FSAH”), may not be completed until the end of the first quarter 2010 or March 31, 2010:
The Board of Trustees of Neuberger Berman High Yield Strategies Fund (NYSE: NHS) has declared a monthly distribution of $0.085 per share. The distribution announced today is payable on January 29, 2010,
Dec 31st, 2009
_______________________________
CEO of Intellicheck Mobilisa, Inc. (NYSE Amex:IDN), Dr. Nelson Ludlow, was featured on TheStreet.com in an interview with Debra Borchardt called “Airlines Checking Out Intellicheck.”
On December 1, 2009, Hecla Mining Company (HL:NYSE) announced that its Board of Directors had elected to declare and pay all dividends in arrears and the next scheduled quarterly dividend for each of its outstanding series of preferred stock.
TaxMasters (TAXS.OB) offers tax relief services specifically designed to reduce and eliminate federal tax debt. They are accustomed to handling the IRS and dealing
Dec 31st, 2009
PennyOmega.com Hot Stock News & Alerts!
________________________________________
FREE Daily Stock Alerts From PennyOmega.com
________________________________________
Thursday Dec. 31, 2009
PennyOmega.com Stock Report!
**************************************************************
Power3 Medical Products (OTCBB:PWRM) (www.Power3Medical.com) is a leading bio-medical company engaged in the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets. Power3's patent-pending technologies are being used to develop screening and diagn